Literature DB >> 31283009

The glycoprotein mucin-1 negatively regulates GalNAc transferase 5 expression in pancreatic cancer.

Thomas Caffrey1, Satish Sagar1, Divya Thomas1, Michelle E Lewallen2, Michael A Hollingsworth1, Prakash Radhakrishnan1.   

Abstract

Aberrant expression of the glycoprotein mucin-1 (MUC1) has been associated with pancreatic cancer progression and metastasis as a result of mediating the oncogenic transcriptional regulation of target genes. In the present study, we demonstrate that MUC1 downregulates the expression of the tumor suppressor polypeptide N-acetylgalactosaminyltransferase 5 in pancreatic cancer. ChIP-on-chip analysis revealed that the MUC1 cytoplasmic tail binds to regulatory elements in the GALNT5 gene. Additionally, MUC1 increases binding of p53 and c-Jun and decreases the binding of Sp1 to the proximal promoter and exonic regions of GALNT5. We also observed that expression of N-acetylgalactosaminyltransferase 5 is inversionally proportional to MUC1 expression in human pancreatic cancer. These results demonstrate that MUC1 downregulates the expression of N-acetylgalactosaminyltransferase 5 in pancreatic cancer by modifying the promoter occupancy of transcription factors through its cytoplasmic domain.
© 2019 Federation of European Biochemical Societies.

Entities:  

Keywords:  GalNAc-T5; MUC1-CT; glycosyltransferase; pancreatic cancer

Mesh:

Substances:

Year:  2019        PMID: 31283009      PMCID: PMC7048170          DOI: 10.1002/1873-3468.13532

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  32 in total

Review 1.  MUC1 mucin: a peacemaker in the lung.

Authors:  K Chul Kim; Erik P Lillehoj
Journal:  Am J Respir Cell Mol Biol       Date:  2008-07-10       Impact factor: 6.914

Review 2.  Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family.

Authors:  Eric P Bennett; Ulla Mandel; Henrik Clausen; Thomas A Gerken; Timothy A Fritz; Lawrence A Tabak
Journal:  Glycobiology       Date:  2011-12-18       Impact factor: 4.313

Review 3.  Cell surface-associated mucins in signal transduction.

Authors:  Pankaj K Singh; Michael A Hollingsworth
Journal:  Trends Cell Biol       Date:  2006-08-09       Impact factor: 20.808

4.  Control of cell cycle progression by c-Jun is p53 dependent.

Authors:  M Schreiber; A Kolbus; F Piu; A Szabowski; U Möhle-Steinlein; J Tian; M Karin; P Angel; E F Wagner
Journal:  Genes Dev       Date:  1999-03-01       Impact factor: 11.361

Review 5.  MUC1 and MUC2 in pancreatic neoplasia.

Authors:  E Levi; D S Klimstra; A Andea; O Basturk; N V Adsay
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

6.  Induction of MUC2 and MUC5AC mucins by factors of the epidermal growth factor (EGF) family is mediated by EGF receptor/Ras/Raf/extracellular signal-regulated kinase cascade and Sp1.

Authors:  Michaël Perrais; Pascal Pigny; Marie-Christine Copin; Jean-Pierre Aubert; Isabelle Van Seuningen
Journal:  J Biol Chem       Date:  2002-06-19       Impact factor: 5.157

7.  MUC1 enhances tumor progression and contributes toward immunosuppression in a mouse model of spontaneous pancreatic adenocarcinoma.

Authors:  Teresa L Tinder; Durai B Subramani; Gargi D Basu; Judy M Bradley; Jorge Schettini; Arefayene Million; Todd Skaar; Pinku Mukherjee
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

8.  Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth.

Authors:  K Taniuchi; R L Cerny; A Tanouchi; K Kohno; N Kotani; K Honke; T Saibara; M A Hollingsworth
Journal:  Oncogene       Date:  2011-05-30       Impact factor: 9.867

9.  MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition.

Authors:  L D Roy; M Sahraei; D B Subramani; D Besmer; S Nath; T L Tinder; E Bajaj; K Shanmugam; Y Y Lee; S I L Hwang; S J Gendler; P Mukherjee
Journal:  Oncogene       Date:  2010-11-22       Impact factor: 9.867

10.  A minimal fragment of MUC1 mediates growth of cancer cells.

Authors:  Sanjeev Mahanta; Shawn P Fessler; Jaehong Park; Cynthia Bamdad
Journal:  PLoS One       Date:  2008-04-30       Impact factor: 3.240

View more
  5 in total

1.  Quantification of Tumor Abnormal Proteins in the Diagnosis and Postoperative Prognostic Evaluation of Gastric Cancer.

Authors:  Chao Gu; Li Xie; Bowen Li; Lu Zhang; Fengyuan Li; Weizhi Wang; Jiang Su; Zekuan Xu
Journal:  Clin Med Insights Oncol       Date:  2022-06-24

2.  Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in pancreatic ductal adenocarcinoma.

Authors:  Imayavaramban Lakshmanan; Saravanakumar Marimuthu; Sanjib Chaudhary; Parthasarathy Seshacharyulu; Satyanarayana Rachagani; Sakthivel Muniyan; Ramakanth Chirravuri-Venkata; Pranita Atri; Sanchita Rauth; Rama Krishna Nimmakayala; Jawed Akhtar Siddiqui; Shailendra K Gautam; Ashu Shah; Gopalakrishnan Natarajan; Seema Parte; Namita Bhyravbhatla; Kavita Mallya; Dhanya Haridas; Geoffrey A Talmon; Lynette M Smith; Sushil Kumar; Apar Kishor Ganti; Maneesh Jain; Moorthy P Ponnusamy; Surinder K Batra
Journal:  Oncogene       Date:  2022-10-21       Impact factor: 8.756

Review 3.  Altered glycosylation in cancer: A promising target for biomarkers and therapeutics.

Authors:  Divya Thomas; Ashok Kumar Rathinavel; Prakash Radhakrishnan
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-11-04       Impact factor: 10.680

Review 4.  MUC1: Structure, Function, and Clinic Application in Epithelial Cancers.

Authors:  Wenqing Chen; Zhu Zhang; Shiqing Zhang; Peili Zhu; Joshua Ka-Shun Ko; Ken Kin-Lam Yung
Journal:  Int J Mol Sci       Date:  2021-06-18       Impact factor: 5.923

5.  ST6GalNAc-I promotes lung cancer metastasis by altering MUC5AC sialylation.

Authors:  Imayavaramban Lakshmanan; Sanjib Chaudhary; Raghupathy Vengoji; Parthasarathy Seshacharyulu; Satyanarayana Rachagani; Joseph Carmicheal; Rahat Jahan; Pranita Atri; Ramakanth Chirravuri-Venkata; Rohitesh Gupta; Saravanakumar Marimuthu; Naveenkumar Perumal; Sanchita Rauth; Sukhwinder Kaur; Kavita Mallya; Lynette M Smith; Subodh M Lele; Moorthy P Ponnusamy; Mohd W Nasser; Ravi Salgia; Surinder K Batra; Apar Kishor Ganti
Journal:  Mol Oncol       Date:  2021-05-01       Impact factor: 6.603

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.